- Home
- DCI
as 05-09-2025 12:34pm EST
Donaldson is a leading manufacturer of filtration systems and replacement parts (including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors). The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.6 billion in revenue and $544 million in operating income in its fiscal 2024.
| Founded: | 1915 | Country: | United States |
| Employees: | N/A | City: | BLOOMINGTON |
| Market Cap: | 7.9B | IPO Year: | 1987 |
| Target Price: | $71.33 | AVG Volume (30 days): | 528.3K |
| Analyst Decision: | Hold | Number of Analysts: | 4 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 3.42 | EPS Growth: | 11.79 |
| 52 Week Low/High: | $57.45 - $78.95 | Next Earning Date: | 06-03-2025 |
| Revenue: | $3,633,400,000 | Revenue Growth: | 4.46% |
| Revenue Growth (this year): | 3% | Revenue Growth (next year): | 3.49% |
Stock Insider Trading Activity of Donaldson Company Inc. (DCI)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Owens James | DCI | Director | Apr 10 '25 | Sell | $62.02 | 18,700 | $1,159,774.00 | 20,246 | |
| SCALF THOMAS R | DCI | President | Mar 17 '25 | Sell | $69.22 | 28,500 | $1,972,770.00 | 28,334 | |
| OBERTON WILLARD D | DCI | Director | Mar 5 '25 | Sell | $68.22 | 7,000 | $477,540.00 | 29,599 | |
| SCALF THOMAS R | DCI | President | Feb 28 '25 | Sell | $68.89 | 29,500 | $2,032,255.00 | 28,334 |
Latest Donaldson Company Inc. News
DCI Breaking Stock News: Dive into DCI Ticker-Specific Updates for Smart Investing
Insider Monkey
a day ago
Should You Expect Upside Potential in Donaldson Company (DCI)?
Business Wire
2 days ago
Univercells Technologies Debuts the scale-X™ Nitro Controller to Expand Access to Large-Scale Viral and Advanced Therapy Manufacturing
Argus Research
3 days ago
DCI: What does Argus have to say about DCI?
Business Wire
4 days ago
Donaldson to Webcast Third Quarter Fiscal 2025 Earnings Conference Call
Business Wire
8 days ago
Donaldson Company to Present at the Oppenheimer 20th Annual Industrial Growth Conference
StockStory
11 days ago
3 Profitable Stocks in Hot Water
Morningstar Research
15 days ago
Analyst Report: Donaldson Company, Inc.
Business Wire
15 days ago
Isolere Bio by Donaldson Passes Most Significant Milestone To-Date, Announces Availability of Manufacturing-Grade IsoTag™ AAV Reagent
Compare DCI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DCI Donaldson Company Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.